Foster Wheeler wins contract with GlaxoSmithKline Biologicals
Foster Wheeler Eastern Private, a subsidiary of Bermuda-based construction and engineering company Foster Wheeler, has won a contract to build a new biotechnology production facility in Singapore for GlaxoSmith-Kline Biologicals.
Foster Wheeler Eastern Private, a subsidiary of Bermuda-based construction and engineering company Foster Wheeler, has won a contract to build a new biotechnology production facility in Singapore for GlaxoSmith-Kline Biologicals.
The state-of-the-art facility includes two production buildings, a quality control and administration and utilities buildings on a site of more than 8.8 hectares in Tuas Biomedical Park in Singapore.
"Key to our success in winning this contract was the performance of the Foster Wheeler team on GSK Biologicals' new vaccine facility in Hungary, which is now complete, and our ability to leverage this successful experience for the new Singaporean facility," said Franco Anselmi, chief executive officer of Foster Wheeler Asia Pacific.
"In addition, our 30-year track record of delivering safe and successful projects in Singapore strongly demonstrates our position as one of the lead-ing engineering,procurement and construction con-tractors in Singapore."
Foster Wheeler Eastern Private is part of its Global Engineering and Construction Group. The Foster Wheeler corporation is based in Hamilton, Bermuda, and its operational headquarters are in Clinton, New Jersey, USA.
